The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Atzen Jonathan F since year 2005.
The trader's CIK number is 1329217.
At the time of this reporting, Atzen Jonathan F is the Director of Advanced Cell Technology, Inc. .
(stock ticker symbol OTCBB:ACTC).
See this page for all insider trading activities at Advanced Cell Technology, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-12-14||OTCBB:ACTC||Advanced Cell Technology, Inc.||Sale||50,000||.20||10,000|
|2007-04-23||GBIW||Genesis Bioventures Inc||Sale||10,000||.12||1,200|
|2007-04-20||GBIW||Genesis Bioventures Inc||Sale||10,000||.12||1,200|
|2007-04-19||GBIW||Genesis Bioventures Inc||Sale||15,000||.10||1,575|
|2007-04-18||GBIW||Genesis Bioventures Inc||Sale||5,000||.12||625|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atzen Jonathan F (Director of Advanced Cell Technology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.